Online J Public Health Inform:女性都关心哪些健康问题?谷歌告诉你

2014-11-30 MedSci MedSci原创

Online J Public Health Inform:女性都关心哪些健康问题?谷歌告诉你 你是接诊过带着打印好的网上搜索的医疗信息来就诊的奇葩患者?据相关报道,在美国约80%医生曾接诊过这样的患者;随着互联网的普及,搜索引擎成为人们获取健康问题的一个重要渠道,那么你知道女性朋友们都关心那些健康问题吗?本文为你揭晓答案。 科学家们将女性健康问题分为5类:产科类、妇科类、妇科泌尿学/更年

Online J Public Health Inform:女性都关心哪些健康问题?谷歌告诉你

你是接诊过带着打印好的网上搜索的医疗信息来就诊的奇葩患者?据相关报道,在美国约80%医生曾接诊过这样的患者;随着互联网的普及,搜索引擎成为人们获取健康问题的一个重要渠道,那么你知道女性朋友们都关心那些健康问题吗?本文为你揭晓答案。

科学家们将女性健康问题分为5类:产科类、妇科类、妇科泌尿学/更年期类、肿瘤类、不孕类,对于每类疾病编制出一系列相关的关键词,通过谷歌工具AdWords计算201212-201312月美国网民对各关键词的检索频率。

结果:最常检索的关键词是怀孕,与怀孕相关的关键词中,怀孕与性爱成为最关注的问题,其次是怀孕与体重;与产科相关的关键词中,人乳头瘤病毒(HPV)备受瞩目,其次是流产、卵巢囊肿;至于避孕,宫内节育器成为最关心的问题,其次是输卵结扎。

妇科泌尿学/更年期类中,荷尔蒙替代检索量最高;不孕类中,如何怀孕成为检索最多的关键词,而有关生育类别,试管婴儿成为检索最多。

乳腺癌是肿瘤类中检索最多的词汇,妇科类的癌症中,宫颈癌、卵巢癌、子宫内膜癌名列前三。

互联网的普及使人们获得健康知识更加方便快捷,可以弥补医患之间对疾病认识的鸿沟根据结果可以分析人们对健康知识的了解方向,同时可以告诉研究者某疾病的流行趋势,同时,根据人们所关心的问题,提供更多相关知识能帮助患者了解更多健康知识,提高网络医学的数量和质量。

原文出处:

Baazeem, M. and H. Abenhaim, Google and Women's Health-Related Issues: What Does the Search Engine Data Reveal? Online J Public Health Inform, 2014. 6(2): p. e187.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=14817, encodeId=94da1481ebb, content=还真没见过, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Thu Jan 29 13:01:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860984, encodeId=236d186098431, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Mon Sep 28 04:21:00 CST 2015, time=2015-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537941, encodeId=cb9c153e941df, content=<a href='/topic/show?id=68af9214410' target=_blank style='color:#2F92EE;'>#谷歌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92144, encryptionId=68af9214410, topicName=谷歌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176f12920672, createdName=isabellayj, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596248, encodeId=f9bc15962480b, content=<a href='/topic/show?id=76172e956f2' target=_blank style='color:#2F92EE;'>#健康问题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27956, encryptionId=76172e956f2, topicName=健康问题)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64a918348691, createdName=xzw119, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621511, encodeId=37791621511ec, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=)]
    2015-01-29 huangshang9812

    还真没见过

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=14817, encodeId=94da1481ebb, content=还真没见过, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Thu Jan 29 13:01:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860984, encodeId=236d186098431, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Mon Sep 28 04:21:00 CST 2015, time=2015-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537941, encodeId=cb9c153e941df, content=<a href='/topic/show?id=68af9214410' target=_blank style='color:#2F92EE;'>#谷歌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92144, encryptionId=68af9214410, topicName=谷歌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176f12920672, createdName=isabellayj, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596248, encodeId=f9bc15962480b, content=<a href='/topic/show?id=76172e956f2' target=_blank style='color:#2F92EE;'>#健康问题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27956, encryptionId=76172e956f2, topicName=健康问题)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64a918348691, createdName=xzw119, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621511, encodeId=37791621511ec, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=)]
    2015-09-28 shizhenshan
  3. [GetPortalCommentsPageByObjectIdResponse(id=14817, encodeId=94da1481ebb, content=还真没见过, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Thu Jan 29 13:01:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860984, encodeId=236d186098431, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Mon Sep 28 04:21:00 CST 2015, time=2015-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537941, encodeId=cb9c153e941df, content=<a href='/topic/show?id=68af9214410' target=_blank style='color:#2F92EE;'>#谷歌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92144, encryptionId=68af9214410, topicName=谷歌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176f12920672, createdName=isabellayj, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596248, encodeId=f9bc15962480b, content=<a href='/topic/show?id=76172e956f2' target=_blank style='color:#2F92EE;'>#健康问题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27956, encryptionId=76172e956f2, topicName=健康问题)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64a918348691, createdName=xzw119, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621511, encodeId=37791621511ec, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=)]
    2014-12-02 isabellayj
  4. [GetPortalCommentsPageByObjectIdResponse(id=14817, encodeId=94da1481ebb, content=还真没见过, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Thu Jan 29 13:01:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860984, encodeId=236d186098431, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Mon Sep 28 04:21:00 CST 2015, time=2015-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537941, encodeId=cb9c153e941df, content=<a href='/topic/show?id=68af9214410' target=_blank style='color:#2F92EE;'>#谷歌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92144, encryptionId=68af9214410, topicName=谷歌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176f12920672, createdName=isabellayj, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596248, encodeId=f9bc15962480b, content=<a href='/topic/show?id=76172e956f2' target=_blank style='color:#2F92EE;'>#健康问题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27956, encryptionId=76172e956f2, topicName=健康问题)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64a918348691, createdName=xzw119, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621511, encodeId=37791621511ec, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=14817, encodeId=94da1481ebb, content=还真没见过, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e1ee1608797, createdName=huangshang9812, createdTime=Thu Jan 29 13:01:00 CST 2015, time=2015-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1860984, encodeId=236d186098431, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Mon Sep 28 04:21:00 CST 2015, time=2015-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537941, encodeId=cb9c153e941df, content=<a href='/topic/show?id=68af9214410' target=_blank style='color:#2F92EE;'>#谷歌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92144, encryptionId=68af9214410, topicName=谷歌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176f12920672, createdName=isabellayj, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596248, encodeId=f9bc15962480b, content=<a href='/topic/show?id=76172e956f2' target=_blank style='color:#2F92EE;'>#健康问题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27956, encryptionId=76172e956f2, topicName=健康问题)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64a918348691, createdName=xzw119, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621511, encodeId=37791621511ec, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Tue Dec 02 10:21:00 CST 2014, time=2014-12-02, status=1, ipAttribution=)]

相关资讯

《2014医生互联网行为洞察报告》:六成医生认可线上诊疗

9月2日,罗德公关与益普索市场研究集团联合发布《2014医生互联网行为洞察报告》(以下简称“《报告》”)。《报告》指出,中国大陆地区有71%的医生首选通过网络等数字化渠道来获取相关医疗信息。 中国大陆7成医生采用网络等方式获取医疗信息 中国大陆、中国香港和中国台湾地区近700名医生接受了此次《报告》的调查。数据显示,99%的受访医生服务于公立医院,受访医生涵盖医院体系的各个职称,包括1

2014年互联网发展的九大趋势 智慧医疗名列其中

对比2013年,他们提到了颠覆:移动创业的机会将不再局限于App这种形态,O2O也将通过粉丝聚集模式彻底改变,三、四线城市的年轻草根创业者还拥有大 把商机,2013年的海外IPO与并购潮将在今年继续。他们也提到了回归理性:电商在极速前进之后需要回归经营本质,智能医疗目前仍难以改变人们的就医方式,互联网与金融的融合远没有尘埃落定。美国部分呈现了更多niche market:烹饪书籍、自我众

皮肤领域移动医疗:改变医疗的风口在哪里?

作者:原北京协和医院医生 现医疗互联网连续创业者 在谈论这个话题之前,需要明确一下医疗和健康的范畴以及区别。医疗服务的要点包括:1.核心在于治疗疾病;2.主要针对病人;3.服务提供者主要是医生;4.为刚性需求;5.具有固有逻辑:诊断、治疗、随诊。与健康范畴之间虽然不能完全划清界限,但是两者差别还是巨大的,因此本篇仅局限于医疗范畴进行讨论。 在医疗范畴内里有哪些参与角色呢?患者、医生